A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...
One especially frightening type of cancer that is extremely difficult to detect and seems to show up more often in Black ...
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.
In November 2023, the United States Food and Drug Administration (FDA) approved enzalutamide, with or without concurrent leuprolide therapy, for conventional imaging-defined non-metastatic ...